Lista de obras -

An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum

artículo científico publicado en 2011

Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokines

artículo científico publicado en 2010

Antibody neutralization and escape by HIV-1

artículo científico publicado en 2003

Antibody-Dependent Cellular Cytotoxicity against Primary HIV-Infected CD4+T Cells Is Directly Associated with the Magnitude of Surface IgG Binding ⬇️

artículo científico publicado el 6 de junio de 2012

Detection of HIV-1 neutralizing antibodies in a human CD4⁺/CXCR4⁺/CCR5⁺ T-lymphoblastoid cell assay system

artículo científico publicado en 2013

Differential inhibition of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and TZM-bl cells by endotoxin-mediated chemokine and gamma interferon production

artículo científico publicado en 2010

Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects

artículo científico publicado en 2016

Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection

artículo científico publicado en 2011

Erratum: Antibody neutralization and escape by HIV-1

artículo científico publicado en 2003

Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages

artículo científico publicado en 2011

Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection

artículo científico publicado en 2009

Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies

artículo científico publicado en 2013

Glycosylation Benchmark Profile for HIV-1 Envelope Glycoprotein Production Based on Eleven Env Trimers

artículo científico publicado en 2017

High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses

artículo científico publicado en 2011

Impact of HIV-1 backbone on neutralization sensitivity: neutralization profiles of heterologous envelope glycoproteins expressed in native subtype C and CRF01_AE backbone

artículo científico publicado en 2013

Infectious virion capture by HIV-1 gp120-specific IgG from RV144 vaccinees

artículo científico publicado en 2013

Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication

artículo científico publicado en 2012

Loss of DNAM-1 contributes to CD8+ T-cell exhaustion in chronic HIV-1 infection

artículo científico publicado en 2010

Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials

artículo científico publicado en 2012

Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones

artículo científico publicado en 2012

Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model

scientific article published on 01 August 2019

Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination

artículo científico publicado en 2010

Phenotypic properties of transmitted founder HIV-1

artículo científico publicado en 2013

Relative resistance of HIV-1 founder viruses to control by interferon-alpha

artículo científico publicado en 2013

Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies.

artículo científico publicado en 2017

Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains.

artículo científico publicado en 2009

Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7

artículo científico publicado en 2012

Lista de obras de

An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum

Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokines

Antibody neutralization and escape by HIV-1

Antibody-Dependent Cellular Cytotoxicity against Primary HIV-Infected CD4+T Cells Is Directly Associated with the Magnitude of Surface IgG Binding ⬇️

Detection of HIV-1 neutralizing antibodies in a human CD4⁺/CXCR4⁺/CCR5⁺ T-lymphoblastoid cell assay system

Differential inhibition of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and TZM-bl cells by endotoxin-mediated chemokine and gamma interferon production

Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects

Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection

Erratum: Antibody neutralization and escape by HIV-1

Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages

Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection

Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies

Glycosylation Benchmark Profile for HIV-1 Envelope Glycoprotein Production Based on Eleven Env Trimers

High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses

Impact of HIV-1 backbone on neutralization sensitivity: neutralization profiles of heterologous envelope glycoproteins expressed in native subtype C and CRF01_AE backbone

Infectious virion capture by HIV-1 gp120-specific IgG from RV144 vaccinees

Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication

Loss of DNAM-1 contributes to CD8+ T-cell exhaustion in chronic HIV-1 infection

Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials

Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones

Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model

Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination

Phenotypic properties of transmitted founder HIV-1

Relative resistance of HIV-1 founder viruses to control by interferon-alpha

Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies.

Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains.

Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7